A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes

The success of T cell-based cancer immunotherapy is limited by tumor's resistance against killing by cytotoxic T lymphocytes (CTLs). Tumor-immune resistance is mediated by cell surface ligands that engage immune-inhibitory receptors on T cells. These ligands represent potent targets for therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Khandelwal, Nisit, Breinig, Marco, Speck, Tobias, Michels, Tillmann, Kreutzer, Christiane, Sorrentino, Antonio, Sharma, Ashwini Kumar, Umansky, Ludmila, Conrad, Heinke, Poschke, Isabel, Offringa, Rienk, König, Rainer, Bernhard, Helga, Machlenkin, Arthur, Boutros, Michael, Beckhove, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403046/
https://www.ncbi.nlm.nih.gov/pubmed/25691366
http://dx.doi.org/10.15252/emmm.201404414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403046/
https://www.ncbi.nlm.nih.gov/pubmed/25691366
http://dx.doi.org/10.15252/emmm.201404414

Ejemplares similares